Is Pfizer Inc. (NYSE: PFE) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Yahoo Finance discussed the stock recently as it posted Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

This NYSE-listed company operates within the Drug Manufacturers – General industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $27.29 and fluctuated between $27.33 as its day high and $26.73 as its day low. The current market capitalization of Pfizer Inc. is $154.09B. A total of 49.76 million shares were traded on the day, compared to an average of 44.50M shares.

Insider Activity

Insider trades can also provide insight into a stock’s future direction. During the recent three months, PFE has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 15 BUYs and 37 SELLs from insiders. Insiders purchased 369,868 shares during that period but sold 545,539.

In the most recent transaction, Gottlieb Scott bought 3,000 shares of PFE for 26.47 per share on Dec 15. After the transaction, the Director now owns 9,000 company shares. In a previous transaction on May 08, Gottlieb Scott bought 1,000 shares at 38.58 per share. PFE shares that Director owns now total 6,000.

Among the insiders who bought shares, Gottlieb Scott acquired of 1,000 shares on May 05 at a per-share price of $38.42. This resulted in the Director holding 5,000 shares of PFE after the transaction. In another insider transaction, PFIZER INC bought 1,811,594 shares at $2.76 per share on Mar 17. Company shares held by the 10% Owner now total 5,952,263.


The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Pfizer Inc. pays an annual dividend of $1.70, resulting in a dividend yield of 6.23%, and it has a price to earnings (P/E) ratio of 77.66. PFE’s most recent ex-dividend date was 1/25/2024 when it declared a $0.42 quarterly dividend that was paid in cash on 3/1/2024. Previously, the company paid the dividend on 12/4/2023 with an ex-dividend date of 11/9/2023. The PFE stock dividend was $0.41 per share in cash.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for PFE in the last 3 months, the mean price target is $31.05 with high estimates of $45.00 and low estimates of $23.00. In terms of 52-week highs and lows, PFE has a high of $44.46 and a low of $25.76.

As of this writing, PFE has an earnings estimate of $0.54 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $0.82 per share and a lower estimate of $0.4. The company reported an EPS of -$0.17 in the last quarter, which was 50.00% higher than expectations of -$0.34.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PFE’s latest balance sheet shows that the firm has $31.07B in Cash & Short Term Investments as of fiscal 2021. There were $37.00B in debt and $42.67B in liabilities at the time. Its Book Value Per Share was $17.17, while its Total Shareholder’s Equity was $77.46B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PFE is Buy with a score of 3.76.

Most Popular

Related Posts